Stock listing
NSE:WOCKPHARMA Wockhardt Limited Share Price
Home listing (NSE) of Wockhardt Limited
Follow Wockhardt Limited into a list and get an email when it puts out news.
Share price · NSE:WOCKPHARMA
₹2,184.40 INR +157.80 (+7.8%)
Close on Nov 20, 2026
- Day range
- ₹2,145.00 – ₹2,214.50 INRNov 20, 2026
- Volume
- 923,229 sharesNov 20, 2026
- Market cap
- ₹354.9B INRAt the close on Nov 20, 2026 · price × 162.5M shares outstanding
- 52-week range
- ₹1,086.70 – ₹2,422.30 INRLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- ₹1.81B INRMedian day 688,530 shares · 2 days with no trades · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NSE:WOCKPHARMA · Home | ₹2,184.40 INR | +157.80 (+7.8%) | 923,229 | ₹2,160.00 | ₹2,214.50 | ₹2,145.00 | ₹2,026.60 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NSE:WOCKPHARMA · INR, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| ₹2,184.40 | +157.80 | +7.8% | ₹2,160.00 | ₹2,214.50 | ₹2,145.00 | 923,229 | |
| ₹2,026.60 | +17.70 | +0.9% | ₹2,018.30 | ₹2,065.00 | ₹2,005.00 | 725,564 | |
| ₹2,008.90 | +4.40 | +0.2% | ₹2,004.50 | ₹2,049.70 | ₹1,992.00 | 319,674 | |
| ₹2,004.50 | -22.70 | -1.1% | ₹2,027.20 | ₹2,059.60 | ₹1,983.40 | 560,334 | |
| ₹2,027.20 | -26.80 | -1.3% | ₹2,050.00 | ₹2,075.50 | ₹2,012.00 | 392,491 | |
| ₹2,054.00 | +19.40 | +1.0% | ₹2,034.60 | ₹2,064.00 | ₹2,025.00 | 342,566 | |
| ₹2,034.60 | +3.10 | +0.2% | ₹2,058.00 | ₹2,070.50 | ₹2,015.10 | 436,046 | |
| ₹2,031.50 | +84.50 | +4.3% | ₹1,992.10 | ₹2,089.00 | ₹1,976.60 | 896,543 | |
| ₹1,947.00 | -42.70 | -2.1% | ₹1,982.00 | ₹1,984.60 | ₹1,903.10 | 668,237 | |
| ₹1,989.70 | +90.70 | +4.8% | ₹1,935.00 | ₹2,032.00 | ₹1,897.00 | 1,639,386 | |
| ₹1,899.00 | +31.00 | +1.7% | ₹1,875.00 | ₹1,913.70 | ₹1,858.20 | 448,001 | |
| ₹1,868.00 | -28.50 | -1.5% | ₹1,851.00 | ₹1,915.00 | ₹1,804.20 | 1,162,132 | |
| ₹1,896.50 | -4.60 | -0.2% | ₹1,903.10 | ₹1,915.00 | ₹1,864.10 | 606,501 | |
| ₹1,901.10 | -21.80 | -1.1% | ₹1,923.00 | ₹1,932.90 | ₹1,872.00 | 506,614 | |
| ₹1,922.90 | +9.50 | +0.5% | ₹1,906.00 | ₹1,960.50 | ₹1,886.40 | 496,447 | |
| ₹1,913.40 | +28.60 | +1.5% | ₹1,885.00 | ₹1,934.00 | ₹1,861.20 | 490,595 | |
| ₹1,884.80 | +75.20 | +4.2% | ₹1,814.80 | ₹1,893.00 | ₹1,805.00 | 524,201 | |
| ₹1,809.60 | +7.90 | +0.4% | ₹1,795.00 | ₹1,834.00 | ₹1,780.50 | 798,498 | |
| ₹1,801.70 | -53.80 | -2.9% | ₹1,857.00 | ₹1,864.00 | ₹1,772.00 | 879,063 | |
| ₹1,855.50 | -21.70 | -1.2% | ₹1,872.00 | ₹1,899.90 | ₹1,846.00 | 457,019 | |
| ₹1,877.20 | -29.10 | -1.5% | ₹1,920.90 | ₹1,926.00 | ₹1,858.00 | 471,545 | |
| ₹1,906.30 | -48.60 | -2.5% | ₹1,963.70 | ₹1,966.00 | ₹1,900.60 | 360,528 | |
| ₹1,954.90 | +5.50 | +0.3% | ₹1,957.00 | ₹1,985.50 | ₹1,941.10 | 448,312 | |
| ₹1,949.40 | -36.70 | -1.8% | ₹1,988.00 | ₹1,988.00 | ₹1,931.20 | 410,296 | |
| ₹1,986.10 | +3.00 | +0.2% | ₹1,986.00 | ₹2,003.90 | ₹1,960.40 | 483,873 | |
| ₹1,983.10 | +19.90 | +1.0% | ₹1,970.00 | ₹2,000.20 | ₹1,901.00 | 1,001,334 | |
| ₹1,963.20 | -33.20 | -1.7% | ₹2,002.90 | ₹2,025.10 | ₹1,945.60 | 881,944 | |
| ₹1,996.40 | -33.20 | -1.6% | ₹2,045.80 | ₹2,064.00 | ₹1,986.10 | 687,125 | |
| ₹2,029.60 | -120.80 | -5.6% | ₹2,150.40 | ₹2,159.80 | ₹2,019.00 | 769,434 | |
| ₹2,150.40 | -26.00 | -1.2% | ₹2,175.00 | ₹2,197.00 | ₹2,130.40 | 463,533 | |
| ₹2,176.40 | +112.90 | +5.5% | ₹2,067.20 | ₹2,184.00 | ₹2,062.00 | 899,270 | |
| ₹2,063.50 | -20.40 | -1.0% | ₹2,083.90 | ₹2,093.90 | ₹2,003.00 | 803,153 | |
| ₹2,083.90 | 0.00 | 0.0% | ₹2,083.90 | ₹2,083.90 | ₹2,083.90 | 0 | |
| ₹2,083.90 | -32.40 | -1.5% | ₹2,110.00 | ₹2,124.00 | ₹2,035.60 | 784,540 | |
| ₹2,116.30 | -77.90 | -3.6% | ₹2,201.10 | ₹2,213.60 | ₹2,106.20 | 823,461 | |
| ₹2,194.20 | +6.60 | +0.3% | ₹2,199.00 | ₹2,255.00 | ₹2,148.00 | 1,274,737 | |
| ₹2,187.60 | -78.00 | -3.4% | ₹2,267.00 | ₹2,267.00 | ₹2,181.00 | 649,952 | |
| ₹2,265.60 | -22.10 | -1.0% | ₹2,290.00 | ₹2,329.90 | ₹2,243.00 | 689,934 | |
| ₹2,287.70 | -42.00 | -1.8% | ₹2,310.00 | ₹2,334.50 | ₹2,265.00 | 824,745 | |
| ₹2,329.70 | +144.30 | +6.6% | ₹2,199.00 | ₹2,360.00 | ₹2,182.10 | 3,834,525 | |
| ₹2,185.40 | -1.90 | -0.1% | ₹2,205.90 | ₹2,247.00 | ₹2,176.80 | 1,006,397 | |
| ₹2,187.30 | +101.20 | +4.9% | ₹2,096.00 | ₹2,225.00 | ₹2,090.00 | 1,771,282 | |
| ₹2,086.10 | +13.80 | +0.7% | ₹2,072.30 | ₹2,109.30 | ₹2,047.30 | 557,349 | |
| ₹2,072.30 | +50.80 | +2.5% | ₹2,025.00 | ₹2,090.10 | ₹2,021.50 | 603,193 | |
| ₹2,021.50 | -42.60 | -2.1% | ₹2,050.00 | ₹2,075.00 | ₹1,967.30 | 1,262,973 | |
| ₹2,064.10 | -115.30 | -5.3% | ₹2,190.00 | ₹2,193.80 | ₹2,055.00 | 851,928 | |
| ₹2,179.40 | 0.00 | 0.0% | ₹2,179.40 | ₹2,179.40 | ₹2,179.40 | 0 | |
| ₹2,179.40 | -41.20 | -1.9% | ₹2,200.00 | ₹2,237.00 | ₹2,167.30 | 1,109,909 | |
| ₹2,220.60 | -28.20 | -1.3% | ₹2,250.00 | ₹2,267.00 | ₹2,197.00 | 693,525 | |
| ₹2,248.80 | +24.80 | +1.1% | ₹2,225.00 | ₹2,272.90 | ₹2,196.00 | 1,394,874 | |
| ₹2,224.00 | +16.00 | +0.7% | ₹2,200.00 | ₹2,240.00 | ₹2,166.00 | 1,343,981 | |
| ₹2,208.00 | +119.30 | +5.7% | ₹2,112.50 | ₹2,236.00 | ₹2,076.20 | 4,319,658 | |
| ₹2,088.70 | +138.10 | +7.1% | ₹1,980.00 | ₹2,108.50 | ₹1,976.10 | 3,557,646 | |
| ₹1,950.60 | +46.30 | +2.4% | ₹1,904.60 | ₹1,982.00 | ₹1,891.40 | 1,056,401 | |
| ₹1,904.30 | +53.70 | +2.9% | ₹1,846.20 | ₹1,911.00 | ₹1,838.00 | 684,958 | |
| ₹1,850.60 | -33.10 | -1.8% | ₹1,883.70 | ₹1,887.80 | ₹1,833.30 | 507,087 | |
| ₹1,883.70 | -93.40 | -4.7% | ₹1,974.90 | ₹1,977.10 | ₹1,872.00 | 852,543 | |
| ₹1,977.10 | +15.10 | +0.8% | ₹1,976.10 | ₹2,045.00 | ₹1,963.10 | 1,581,060 | |
| ₹1,962.00 | +79.90 | +4.2% | ₹1,883.10 | ₹1,987.00 | ₹1,874.00 | 1,210,241 | |
| ₹1,882.10 | -17.50 | -0.9% | ₹1,890.00 | ₹1,932.30 | ₹1,873.60 | 310,259 | |
| ₹1,899.60 | -1.40 | -0.1% | ₹1,895.10 | ₹1,914.20 | ₹1,869.60 | 241,579 | |
| ₹1,901.00 | +14.70 | +0.8% | ₹1,888.00 | ₹1,909.20 | ₹1,867.70 | 306,988 | |
| ₹1,886.30 | +55.70 | +3.0% | ₹1,831.10 | ₹1,898.80 | ₹1,830.00 | 559,221 | |
| ₹1,830.60 | +4.60 | +0.3% | ₹1,844.00 | ₹1,852.40 | ₹1,825.00 | 258,015 |
Splits
1 split · NSE:WOCKPHARMA · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 2-for-1 | Split |
- Ticker
- NSE:WOCKPHARMA
- Asset type
- Stock
- Sector
- Health care
- Industry
- Pharmaceuticals
- Exchange
- NSE
- Currency
- INR
What changed lately
Latest news release · Nov 2, 2026
Wockhardt Limited has informed the Exchange regarding a press release dated November 02, 2026, titled "Pursuant to Regulation 30 of the Listing Regulations, please find enclosed Press Release on the Un-audited Financial Results (Standalone and Consolidated) for the quarter and half year ended 30th September, 2026.".
Latest deck · Jun 4, 2026
Investor Presentation (June 2026)
Investor deck · 36 slides
Latest news
Wockhardt Limited has informed the Exchange regarding a press release dated November 02, 2026, titled "Pursuant to Regulation 30 of the Listing Regulations, please find enclosed Press Release on the Un-audited Financial Results (Standalone and Consolidated) for the quarter and half year ended 30th September, 2026.".
Nov 2, 2026
Closed ₹1,868.00 (-1.5%) on Nov 3, 2026
Wockhardt Limited Press Release Aug 10 2026
Aug 10, 2026
Closed ₹1,909.40 (-1.1%) on Aug 11, 2026
Wockhardt Receives U.S. FDA Approval for ZAYNICH™ (cefepime and zidebactam), a Novel Intravenous Antibiotic for the Treatment of Adult Patients with Complicated Urinary Tract Infection Including Pyelonephritis
Jun 1, 2026
Closed ₹1,966.20 (-8.7%) on Jun 2, 2026
Press Release May 30 2026
May 30, 2026
Closed ₹2,152.90 (+6.0%) on Jun 1, 2026
Press Release May 28 2026
May 27, 2026
Closed ₹1,771.00 (0.0%) on May 28, 2026
Press Release May 04 2026
May 4, 2026
Closed ₹1,425.00 (+2.1%) on May 4, 2026
Press Release Mar 30 2026
Mar 30, 2026
Closed ₹1,267.60 (+7.8%) on Apr 1, 2026
Wockhardt Limited Press Release Mar 30 2026
Mar 29, 2026
Closed ₹1,175.70 (-1.2%) on Mar 30, 2026
Press Release Feb 10 2026
Feb 10, 2026
Closed ₹1,402.10 (-1.9%) on Feb 11, 2026
Press Release Jan 27 2026
Jan 27, 2026
Closed ₹1,356.70 (+0.6%) on Jan 28, 2026
Wockhardt Limited on 6ix
- Sector
- Health care
- Industry
- Pharmaceuticals
- News releases
- 15 in the last 12 months · 75 in all · newest Nov 2, 2026 · oldest 2012
- Decks
- 22 decks · latest Jun 4, 2026
Where Wockhardt Limited is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NSE:WOCKPHARMA · Home listing · This page | NSE | India | INR |
| BSE:WOCKPHARMA | BSE | India | INR |
Valuation
P/E 86.6× against a median of 17.3×: the highest of 9 Pharmaceuticals companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026
- Enterprise value
- ₹370.5B INR
- P/E
- 86.6×
- EV/sales
- 9.9×
- EV/EBITDA
- 51.4×
- Price/book
- 6.9×
- Gross margin
- 45.4%
- Operating margin
- 13.1%
- Net margin
- 10.9%
- Debt to equity
- 0.4×
- Beta
- No index for this market yet
Pharmaceuticals: the 10 companies nearest in size, of 492 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Wockhardt Limited · NSE:WOCKPHARMA | US$3.83B | US$4.00B | 86.6× | 9.9× | 51.4× | 6.9× | 10.9% | 0.4× | n/a |
| Shenzhen Salubris Pharmaceuticals Co., Ltd. Class A · SZSE:002294 | US$4.31B | US$4.16B | n/a | n/a | n/a | 3.3× | n/a | 0.1× | n/a |
| 3SBio, Inc. · HKEX:1530 | US$4.02B | US$1.58B | 3.1× | 0.6× | 0.9× | 1.0× | 47.9% | 0.1× | n/a |
| Shijiazhuang Yiling Pharmaceutical Co., Ltd. Class A · SZSE:002603 | US$3.73B | US$3.35B | 18.0× | 2.8× | n/a | 2.2× | 17.4% | 0.0× | n/a |
| Organon & Co. · NYSE:OGN | US$3.65B | US$10.75B | 17.1× | 1.8× | n/a | 3.1× | 3.5% | 7.2× | 0.52 |
| Tarsus Pharmaceuticals, Inc. · NASDAQ:TARS | US$3.60B | US$3.36B | n/a | 4.9× | n/a | 34.6× | −102.9% | 0.7× | 0.62 |
| Laboratorios Farmaceuticos Rovi, S.A. · BME:ROVI | US$3.54B | US$3.52B | 17.4× | 4.2× | 15.8× | 4.6× | 23.9% | 0.1× | n/a |
| China Resources Pharmaceutical Group Ltd. · HKEX:3320 | US$3.51B | US$14.04B | 5.2× | 0.3× | 5.1× | 0.4× | 1.5% | 1.9× | n/a |
| Zhejiang Huahai Pharmaceutical Co., Ltd. Class A · SSE:600521 | US$3.50B | US$3.65B | 24.6× | 2.5× | n/a | 2.3× | 9.8% | 0.3× | n/a |
| Orion Oyj Class A · OMXHEX:ORNAV | US$3.42B | US$3.40B | 4.7× | 1.4× | 3.5× | 2.2× | 30.3% | 0.1× | n/a |
| Jiangsu Nhwa Pharmaceutical Co., Ltd. Class A · SZSE:002262 | US$3.42B | US$2.79B | 20.8× | 3.0× | n/a | 2.6× | 17.7% | 0.0× | n/a |
| Median of the others | US$3.57B | US$3.46B | 17.3× | 2.5× | 4.3× | 2.5× | 17.4% | 0.1× | 0.57 |
Team and board
Officers
| Officer | Role |
|---|---|
| Deepak R. Madnani | Chief Financial Officer – Finance |
| Gopalakrishnan Venkatesan | President & VP Business Development – Morton Grove Pharmaceuticals & Wockhardt USA LLC |
| Debolina Partap | Sr. Vice President – Legal |
| Om Narayan | Senior Vice President – Biotech R&D |
| Ajay Sahni | Managing Director – Wockhardt Bio AG; Managing Director – Pinewood Healthcare |
| Annapurna Das | President – India Business & NCE Emerging Markets |
| HUZAIFA KHORAKIWALA | Executive Director |
| Mahesh V. Patel | Chief Scientific Officer – New Drug Discovery |
| MURTAZA KHORAKIWALA | Managing Director |
| Ravi Limaye | Managing Director – Wockhardt UK |
| Sumit Garg | Chief Digital & Information Officer (CDIO) |
Board
| Director | Role |
|---|---|
| HABIL KHORAKIWALA | Founder Chairman |
| AKHILESH GUPTA | Independent Director |
| Amb. AHMAD JAVED | Independent Director |
| AMELIA FERNANDES | Independent Director |
| HUZAIFA KHORAKIWALA | Executive Director |
| OM PRAKASH BHATT | Independent Director |
| VINESH KUMAR JAIRATH | Independent Director |
| ZAHABIYA KHORAKIWALA | Non-Executive Director |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (June 2026) | Investor deck | 36 slides | Jun 4, 2026 |
| Investor Presentation (June 2025) | Investor deck | 34 slides | Jun 5, 2025 |
| Investor Presentation (October 2024) | Investor deck | 44 slides | Oct 21, 2024 |
| Investor Presentation (October 2024) | Investor deck | 43 slides | October 2024 |
| Investor Presentation (February 2024) | Investor deck | 29 slides | Feb 26, 2024 |
| Investor Presentation (February 2024) | Investor deck | 28 slides | February 2024 |
| ESG Presentation (August 2023) | Sustainability | 9 slides | Aug 1, 2023 |
| ESG Presentation (July 2023) | Sustainability | 8 slides | July 2023 |
| Investor Presentation (February 2023) | Investor deck | 35 slides | Feb 21, 2023 |
| Investor Presentation (February 2023) | Investor deck | 34 slides | February 2023 |
All 22 decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (March 2022) | Investor deck | 18 slides | Mar 8, 2022 |
| Q1 FY2016 Earnings Presentation | Earnings | 17 slides | August 2015 |
| Q4 FY2015 Earnings Presentation | Earnings | 21 slides | May 2015 |
| Q3 FY2014 Earnings Presentation | Earnings | 23 slides | February 2014 |
| Investor Presentation (October 2013) | Investor deck | 33 slides | October 2013 |
| Investor Presentation (August 2013) | Investor deck | 21 slides | August 2013 |
| Investor Presentation (May 2013) | Investor deck | 26 slides | May 2013 |
| Investor Presentation (February 2013) | Investor deck | 33 slides | February 2013 |
| Investor Presentation (November 2012) | Investor deck | 49 slides | November 2012 |
| Investor Presentation (February 2007) | Investor deck | 33 slides | February 2007 |
| Investor Presentation (July 2006) | Investor deck | 29 slides | July 2006 |
| Q2 2005 Earnings Presentation | Earnings | 35 slides | Jul 19, 2005 |
Financials
Annual, in INR
Income statement
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 33.7B | 30.4B | 28.3B | 26.6B | 32.3B | 27.1B | 28.4B | 35.7B | 39.2B | 39.7B |
| Cost of revenue | 20.8B | 12.1B | 12.3B | 11.7B | 13.5B | 12.1B | 12.7B | 17.2B | 18.5B | 16.9B |
| Gross profit | 12.9B | 18.3B | 16.0B | 14.8B | 18.8B | 15.0B | 15.8B | 18.5B | 20.7B | 22.7B |
| Research and development | 1.20B | 1.19B | 1.32B | 1.41B | 1.43B | 1.72B | 2.08B | 2.91B | 2.87B | 3.97B |
| Selling, general and administrative | 2.75B | 1.17B | 1.05B | 1.10B | 1.48B | 1.35B | 1.02B | 2.23B | 2.69B | 3.03B |
| Operating income | 4.03B | 10.5B | 8.36B | 7.06B | 9.87B | 5.33B | 5.99B | 6.64B | 7.54B | 8.23B |
| Depreciation and amortization | 2.27B | 2.17B | 2.23B | 2.51B | 2.47B | 2.46B | 2.26B | 1.66B | 1.50B | 1.49B |
| EBITDA | 6.30B | 12.7B | 10.6B | 9.57B | 12.3B | 7.79B | 8.24B | 8.30B | 9.03B | 9.72B |
| Interest expense | 2.13B | 2.54B | 3.05B | 3.02B | 2.99B | 2.49B | 2.75B | 2.64B | 2.50B | 2.22B |
| Income before tax | 2.38B | -160.0M | -4.20B | -6.24B | -4.11B | -5.68B | -3.42B | -4.47B | -6.41B | -2.47B |
| Income tax | 390.0M | 410.0M | 520.0M | -30.0M | -1.32B | -2.72B | -2.04B | -1.35B | 257.0M | -211.1M |
| Net income | 2.13B | -470.0M | -4.63B | -5.59B | -2.44B | 6.86B | -692.2M | -1.95B | -6.08B | -1.96B |
| Earnings per share, basic | 13.10 | -3.00 | -32.10 | -38.80 | -20.24 | 57.10 | -6.25 | -17.58 | -55.01 | -17.71 |
Balance sheet
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 2.50B | 1.91B | 5.05B | 900.0M | 3.70B | 2.32B | 2.19B | 3.97B | 8.97B | 9.64B |
| Short-term investments | 4.12B | 4.22B | 160.0M | 600.0M | 90.0M | 54.4M | 457.3M | 457.7M | 4.00B | 11.5B |
| Receivables | 5.88B | 6.61B | 6.18B | 7.97B | 9.68B | 9.18B | 12.5B | 13.0B | 9.71B | 10.6B |
| Inventory | 8.87B | 7.25B | 6.42B | 6.58B | 7.69B | 7.99B | 6.90B | 8.19B | 8.56B | 11.1B |
| Current assets | 26.1B | 24.6B | 21.8B | 22.1B | 25.9B | 24.2B | 24.3B | 28.0B | 33.8B | 45.4B |
| Property, plant and equipment | 22.3B | 23.1B | 24.4B | 28.6B | 29.1B | 33.2B | 30.2B | 29.9B | 29.1B | |
| Goodwill | 10.3B | 9.77B | 9.53B | 9.45B | 8.91B | 9.04B | 8.75B | 8.21B | 8.41B | 7.37B |
| Total assets | 86.2B | 81.3B | 76.5B | 76.8B | 82.4B | 77.7B | 81.8B | 78.3B | 81.6B | 89.7B |
| Accounts payable | 5.63B | 5.92B | 7.66B | 8.67B | 9.21B | 6.96B | 8.95B | 8.40B | 6.02B | 5.34B |
| Current liabilities | 16.2B | 20.4B | 27.9B | 34.4B | 32.1B | 31.2B | 35.0B | 28.5B | 26.9B | 19.8B |
| Long-term debt | 15.2B | 12.1B | 8.91B | 2.24B | 3.55B | 5.03B | 12.4B | 18.9B | 21.7B | 31.9B |
| Total debt | 22.3B | 20.2B | 23.6B | 21.8B | 22.0B | 26.7B | 35.8B | 33.7B | 37.5B | 41.5B |
| Total liabilities | 33.3B | 34.8B | 39.9B | 40.2B | 40.4B | 40.1B | 51.2B | 48.3B | 49.6B | 52.5B |
| Shareholders' equity | 49.4B | 43.5B | 33.6B | 33.5B | 38.5B | 33.8B | 26.7B | 26.7B | 28.5B | 33.4B |
| Shares outstanding | 162.6M | 156.9M | 144.3M | 144.1M | 120.6M | 120.1M | 110.7M | 110.7M | 110.6M | 110.5M |
Cash flow
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 2.00B | -220.0M | 2.19B | 1.53B | 4.13B | -2.87B | 6.49B | 1.83B | 684.4M | -2.69B |
| Capital spending | -1.36B | -940.0M | -2.16B | -2.09B | -2.12B | -1.66B | -1.72B | -2.75B | -3.07B | -4.11B |
| Free cash flow | 640.0M | -1.16B | 30.0M | -560.0M | 2.01B | -4.53B | 4.77B | -915.5M | -2.39B | -6.80B |
| Cash from investing | -2.75B | -7.83B | -1.37B | -1.25B | -2.01B | 14.7B | -1.56B | 945.7M | 6.30B | -6.86B |
| Cash from financing | 1.41B | 4.09B | 3.34B | -3.15B | -710.0M | -11.7B | -6.80B | -7.76B | -7.69B | 12.5B |
| Dividends paid | -20.0M | -5.30M | -5.30M | -200.0K | -1.00M | -1.38B | ||||
| Share buybacks | 9.83B | 4.68B | 0 | 7.48B | -3.54B | 300.0K | -2.71B | 500.0K | 200.0K | |
| Change in cash | 960.0M | -3.93B | 4.15B | -2.80B | 1.38B | 129.1M | -1.78B | -5.00B | -664.0M | 3.01B |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| Wockhardt Limited has informed the Exchange regarding a press release dated November 02, 2026, titled "Pursuant to Regulation 30 of the Listing Regulations, please find enclosed Press Release on the Un-audited Financial Results (Standalone and Consolidated) for the quarter and half year ended 30th September, 2026.". | Nov 2, 2026 | Results | NSE India |
| Wockhardt Limited Press Release Aug 10 2026 | Aug 10, 2026 | Other filings | NSE India |
| Press Release May 30 2026 | May 30, 2026 | Other filings | NSE India |
| Press Release May 28 2026 | May 27, 2026 | Operations update | NSE India |
| Press Release May 04 2026 | May 4, 2026 | Results | NSE India |
| Wockhardt Limited Press Release Mar 30 2026 | Mar 29, 2026 | Other filings | NSE India |
| Press Release Feb 10 2026 | Feb 10, 2026 | Other filings | NSE India |
| Wockhardt Limited Press Release Jan 27 2026 | Jan 26, 2026 | Other filings | NSE India |
| Wockhardt Limited Press Release Jan 07 2026 | Jan 6, 2026 | Other filings | NSE India |
| Press Release Dec 31 2025 | Dec 31, 2025 | Other filings | NSE India |
All 58 filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| Press Release Dec 01 2025 | Dec 1, 2025 | Other filings | NSE India |
| Press Release Nov 03 2025 | Nov 3, 2025 | Results | NSE India |
| Wockhardt Limited Press Release Oct 01 2025 | Sep 30, 2025 | Operations update | NSE India |
| Press Release Sep 25 2025 | Sep 25, 2025 | Other filings | NSE India |
| Press Release Aug 08 2025 | Aug 8, 2025 | Results | NSE India |
| Wockhardt Limited Press Release Jul 28 2025 | Jul 27, 2025 | Other filings | NSE India |
| Press Release Jul 11 2025 | Jul 11, 2025 | Operations update | NSE India |
| Press Release May 29 2025 | May 29, 2025 | Other filings | NSE India |
| Wockhardt Limited Press Release Apr 01 2025 | Mar 31, 2025 | Operations update | NSE India |
| Press Release Feb 07 2025 | Feb 7, 2025 | Other filings | NSE India |
| Wockhardt Limited Press Release Jan 31 2025 | Jan 30, 2025 | Operations update | NSE India |
| Wockhardt Limited Press Release Jan 13 2025 | Jan 12, 2025 | Operations update | NSE India |
| Press Release Jan 02 2025 | Jan 2, 2025 | Operations update | NSE India |
| Wockhardt Limited Press Release Dec 16 2024 | Dec 15, 2024 | Other filings | NSE India |
| Press Release Nov 13 2024 | Nov 13, 2024 | Results | NSE India |
| Wockhardt Limited Press Release Oct 16 2024 | Oct 15, 2024 | Operations update | NSE India |
| Press Release Oct 11 2024 | Oct 11, 2024 | Operations update | NSE India |
| Press Release Oct 07 2024 | Oct 7, 2024 | Operations update | NSE India |
| Wockhardt Limited Press Release Sep 19 2024 | Sep 18, 2024 | Operations update | NSE India |
| Wockhardt Limited Press Release Sep 16 2024 | Sep 15, 2024 | Other filings | NSE India |
| Press Release Aug 09 2024 | Aug 9, 2024 | Results | NSE India |
| Press Release Jun 28 2024 | Jun 28, 2024 | Operations update | NSE India |
| Press Release May 28 2024 | May 28, 2024 | Other filings | NSE India |
| Press Release Mar 11 2024 | Mar 11, 2024 | Other filings | NSE India |
| Press Release Feb 14 2024 | Feb 14, 2024 | Other filings | NSE India |
| Press Release Dec 11 2023 | Dec 11, 2023 | Operations update | NSE India |
| Press Release Nov 14 2023 | Nov 14, 2023 | Results | NSE India |
| Press Release Aug 14 2023 | Aug 14, 2023 | Results | NSE India |
| Press Release May 26 2023 | May 26, 2023 | Results | NSE India |
| Press Release Aug 16 2022 | Aug 16, 2022 | Other filings | NSE India |
| Press Release Mar 20 2022 | Mar 20, 2022 | Operations update | NSE India |
| Press Release Mar 16 2022 | Mar 16, 2022 | Other filings | NSE India |
| Press Release Feb 08 2022 | Feb 8, 2022 | Other filings | NSE India |
| Press Release Jan 27 2022 | Jan 27, 2022 | Other filings | NSE India |
| Press Release Nov 08 2021 | Nov 8, 2021 | Other filings | NSE India |
| Press Release Aug 26 2021 | Aug 26, 2021 | Other filings | NSE India |
| Press Release Aug 13 2021 | Aug 13, 2021 | Other filings | NSE India |
| Press Release Jul 27 2021 | Jul 27, 2021 | Other filings | NSE India |
| Press Release Jul 22 2021 | Jul 22, 2021 | Other filings | NSE India |
| Press Release Jul 05 2021 | Jul 5, 2021 | Other filings | NSE India |
| Press Release May 27 2021 | May 27, 2021 | Results | NSE India |
| Press Release Feb 10 2021 | Feb 10, 2021 | Other filings | NSE India |
| Press Release Jan 29 2021 | Jan 29, 2021 | Results | NSE India |
| Press Release Dec 01 2020 | Dec 1, 2020 | Other filings | NSE India |
| Press Release Nov 02 2020 | Nov 2, 2020 | Results | NSE India |
| Press Release Aug 31 2020 | Aug 31, 2020 | Management or board change | NSE India |
| Press Release Aug 29 2020 | Aug 29, 2020 | Other filings | NSE India |
| Press Release Aug 03 2020 | Aug 3, 2020 | Other filings | NSE India |
Cap table
Built by 6ix from Wockhardt Limited’s releases
- Common shares
- 162,492,169
- Fully diluted
- 162,492,169
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 162,492,169 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 162,492,169 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Ajay Sahni | Managing Director – Wockhardt Bio AG; Managing Director – Pinewood Healthcare · Since at least Nov 4, 2026 |
| AKHILESH GUPTA | Independent Director · Since at least Nov 6, 2026 |
| Amb. AHMAD JAVED | Independent Director · Since at least Nov 6, 2026 |
| Amelia Fernandes | Independent Director · Since at least Nov 6, 2026 |
| Annapurna Das | President – India Business & NCE Emerging Markets · Since at least Nov 6, 2026 |
| Debolina Partap | Sr. Vice President – Legal · Since at least Nov 6, 2026 |
| Deepak R. Madnani | Chief Financial Officer – Finance · Since at least Nov 6, 2026 |
| Gopalakrishnan Venkatesan | President & VP Business Development – Morton Grove Pharmaceuticals & Wockhardt USA LLC · Since at least Nov 6, 2026 |
| HABIL KHORAKIWALA | Founder Chairman · Since at least Jun 1, 2026 |
| HUZAIFA KHORAKIWALA | Executive Director · Since at least Nov 6, 2026 |
All 18 people
| Person | Seat |
|---|---|
| Mahesh V. Patel | Chief Scientific Officer – New Drug Discovery · Since at least Nov 6, 2026 |
| MURTAZA KHORAKIWALA | Managing Director · Since at least Nov 6, 2026 |
| Om Narayan | Senior Vice President – Biotech R&D · Since at least Nov 6, 2026 |
| Om Prakash Bhatt | Independent Director · Since at least Nov 6, 2026 |
| Ravi Limaye | Managing Director – Wockhardt UK · Since at least Nov 6, 2026 |
| Sumit Garg | Chief Digital & Information Officer (CDIO) · Since at least Nov 6, 2026 |
| VINESH KUMAR JAIRATH | Independent Director · Since at least Nov 6, 2026 |
| ZAHABIYA KHORAKIWALA | Non-Executive Director · Since at least Nov 6, 2026 |
Log in to ask 6ix AI your own questions about Wockhardt Limited.